Medical Science News

RSS

Personal factors drive risky drinking at work more than job stress

The study identifies age, education, and smoking as critical factors in high-risk drinking among workers, emphasizing the need for targeted interventions.

15 Jan 2026

Weekly THC levels reveal when cannabis use becomes a disorder

Weekly cannabis use accurately predicts the risk of developing cannabis use disorder.

15 Jan 2026

Study highlights potential of ferroptosis-based approaches to treat cancer

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a promising avenue to treat cancer, according to new research by UTHealth Houston.

14 Jan 2026

Scientists reveal how cholera bacteria activate toxin genes in the human gut

Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of deaths reported worldwide each year.

14 Jan 2026

Bacterial metabolite enhances immune checkpoint therapy against lung cancer

UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer immunotherapy treatment in mice and can now be made into a drug for testing in humans.

14 Jan 2026

Scientists uncover promising therapeutic target for autoimmune disease affecting the brain

Scientists have identified a promising target for treatment of a devasting autoimmune disease affecting the brain.

14 Jan 2026

Rare immune events link Epstein Barr virus to early multiple sclerosis damage

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself.

14 Jan 2026

Engineered vessels boost retinal organoid function, enabling advanced disease modeling

Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply of nutrients and oxygen in the densely packed tissues is limited, leading to cell death.

14 Jan 2026

Lund researchers create "recipe book" for reprogramming immune cells to fight disease

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation.

14 Jan 2026

HIF1 protein identified as key driver of tendon pain

Overuse of our tendons can cause painful medical conditions for which only limited treatment options exist. Researchers have now deciphered an important molecular mechanism that triggers these problems.

14 Jan 2026

Researchers develop new method to 3D print micrometer-sized structures within cells

Researchers have developed a way to 3D print custom micrometer-sized structures directly into the interior of living cells.

14 Jan 2026

Disease-responsive nanoparticles enable ghrelin mRNA therapy in osteoarthritis

Nitin Joshi, PhD, and Jingjing Gao, PhD, of the Department of Anesthesiology at Mass General Brigham, are the co-senior authors of a paper published in Nature Nanotechnology, "A disease-severity-responsive nanoparticle enables potent ghrelin mRNA therapy in osteoarthritis." Mahima Dewani, PhD, is the lead author of this study.

14 Jan 2026

RAS-MAPK inhibition halts spinal deformity in neurofibromatosis type 1 mouse model

Spinal deformities such as scoliosis and kyphosis are among the most serious complications of neurofibromatosis type 1 (NF1), a genetic disorder that affects about one in 3,000 people.

14 Jan 2026

Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study

A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a new study by researchers at Umeå University, Sweden.

14 Jan 2026

PFAS exposure linked to gestational diabetes and insulin problems

Exposure to per- and polyfluoroalkyl substances (PFAS), a class of highly persistent environmental chemicals commonly referred to as "forever chemicals," is associated with a higher risk of gestational diabetes mellitus and altered markers of insulin resistance and insulin secretion, according to a new systematic review and meta-analysis led by researchers at the Icahn School of Medicine at Mount Sinai.

14 Jan 2026

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly approved immunotherapy called tarlatamab.

14 Jan 2026

Silent thief of sight: Rutgers Health experts highlight glaucoma risks, early detection

1
2
3
4
...
4085
Next

Medical Science News

Personal factors drive risky drinking at work more than job stress

Weekly THC levels reveal when cannabis use becomes a disorder

Study highlights potential of ferroptosis-based approaches to treat cancer

Scientists reveal how cholera bacteria activate toxin genes in the human gut

Bacterial metabolite enhances immune checkpoint therapy against lung cancer

Scientists uncover promising therapeutic target for autoimmune disease affecting the brain

Rare immune events link Epstein Barr virus to early multiple sclerosis damage

Engineered vessels boost retinal organoid function, enabling advanced disease modeling

Lund researchers create "recipe book" for reprogramming immune cells to fight disease

HIF1 protein identified as key driver of tendon pain

Researchers develop new method to 3D print micrometer-sized structures within cells

Disease-responsive nanoparticles enable ghrelin mRNA therapy in osteoarthritis

RAS-MAPK inhibition halts spinal deformity in neurofibromatosis type 1 mouse model

Bacterial toxin shrinks tumors, enhances immune response in colorectal cancer study

PFAS exposure linked to gestational diabetes and insulin problems

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

Silent thief of sight: Rutgers Health experts highlight glaucoma risks, early detection

Cannabidiol could become a therapeutic tool for fetal alcohol spectrum disorder

DTU researchers discover gut bacteria link to reduced allergy and asthma risk

New metabolomic signature predicts type 2 diabetes risk beyond traditional factors

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News